NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.270
+0.010 (0.79%)
Mar 11, 2026, 4:00 PM EDT - Market closed

NovaBay Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3315112090146
Market Cap Growth
936.82%28.15%-42.27%-77.94%-38.23%62.87%
Enterprise Value
31.8415.4611.5919.0483.47133.74
Last Close Price
1.273.0135.70341.252306.704269.15
PE Ratio
10.23-0.24-0.05-0.19-2.51-2.25
PS Ratio
3.221.501.101.388.8114.66
PB Ratio
20.30-113.793.461.888.8411.82
P/TBV Ratio
1.60-15.820.260.301.621.99
P/FCF Ratio
11.24-2.79-2.76-2.93-9.73-30.67
P/OCF Ratio
11.22-2.79-2.77-2.98-9.78-30.84
EV/Sales Ratio
3.091.581.111.328.1813.46
EV/EBITDA Ratio
--2.67-2.86-1.37-9.55-20.98
EV/EBIT Ratio
--2.65-2.83-1.32-9.42-20.81
EV/FCF Ratio
10.78-2.93-2.79-2.81-9.03-28.17
Debt / Equity Ratio
0.25-9.370.330.150.030.01
Debt / EBITDA Ratio
-0.57-0.29-0.64-0.15-0.06-0.08
Debt / FCF Ratio
0.24-0.32-0.63-0.30-0.06-0.11
Net Debt / Equity Ratio
-1.21-9.63-0.09-0.31-0.68-0.93
Net Debt / EBITDA Ratio
0.78-0.210.080.240.801.80
Net Debt / FCF Ratio
-0.33-0.240.080.490.752.41
Asset Turnover
2.971.570.820.710.520.75
Inventory Turnover
-13.172.221.991.937.22
Quick Ratio
1.850.150.841.722.664.61
Current Ratio
2.000.681.672.663.835.03
Return on Equity (ROE)
-250.10%-339.22%-39.76%-102.37%-51.79%-165.96%
Return on Assets (ROA)
-49.90%-93.75%-32.26%-71.41%-45.20%-48.55%
Return on Invested Capital (ROIC)
-132.72%-184.25%-72.81%-140.18%-124.76%-422.15%
Return on Capital Employed (ROCE)
-131.65%-218.85%-48.55%-88.24%-53.81%-71.65%
Earnings Yield
9.77%-420.97%-1948.74%-517.95%-39.91%-44.48%
FCF Yield
8.90%-35.89%-36.23%-34.10%-10.28%-3.26%
Buyback Yield / Dilution
2.13%-21.15%-4.93%-8.58%-1.97%-8.46%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q